Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · IEX Real-Time Price · USD

2.890

+0.035 (1.23%)

At close: Apr 26, 2024, 4:00 PM

2.910

+0.020 (0.69%)

After-hours: Apr 26, 2024, 4:42 PM EDT

Allogene Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	493	540	907	2,126	3,541	3,167	3,272
Market Cap Growth	-	-40.45%	-57.34%	-39.95%	11.80%	-3.19%	-
Enterprise Value	34	81	379	1,659	2,703	2,632	2,811
PE Ratio	-1.65	-1.65	-2.66	-11.68	-11.19	-17.16	-15.47
PS Ratio	5193.57	5685.98	5814.63	18.64	-	-	-
PB Ratio	0.96	1.06	1.36	2.30	3.28	5.04	4.65
P/FCF Ratio	-2.26	-2.26	-4.02	-10.31	-19.56	-16.83	-68.32
P/OCF Ratio	-2.27	-2.27	-4.11	-11.51	-30.76	-23.06	-73.27
EV/Sales Ratio	362.11	854.52	2432.50	14.54	-	-	-
EV/EBITDA Ratio	-0.26	-0.26	-1.16	-9.67	-8.75	-14.58	-13.56
EV/EBIT Ratio	-0.25	-0.25	-1.11	-9.11	-8.54	-14.23	-13.50
EV/FCF Ratio	-0.34	-0.34	-1.68	-8.04	-14.93	-13.99	-58.70
Quick Ratio	12.38	12.38	9.82	9.76	8.88	16.17	15.64
Current Ratio	12.38	12.38	9.84	9.84	8.96	16.46	15.89
Asset Turnover	0	0	0	0.10	0	0	0
Interest Coverage	-	-	-	-	-	-	-62.02
Return on Equity (ROE)	-56.70%	-56.70%	-44.40%	-18.30%	-31.90%	-28.60%	-60.20%
Return on Assets (ROA)	-45.60%	-45.60%	-37.60%	-16.40%	-28.80%	-25.50%	-54.70%
Return on Capital (ROIC)	-63.98%	-63.98%	-50.31%	-19.48%	-23.92%	-32.11%	-27.42%
Earnings Yield	-66.33%	-60.59%	-37.53%	-8.56%	-8.94%	-5.83%	-6.47%
FCF Yield	-48.49%	-44.29%	-24.88%	-9.70%	-5.11%	-5.94%	-1.46%
Buyback Yield / Dilution	-9.63%	-9.63%	-5.39%	-12.84%	-19.11%	-249.11%	-
Total Shareholder Return	-9.63%	-9.63%	-5.39%	-12.84%	-19.11%	-249.11%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).